Day: August 3, 2021

Categories
General

FM, Finnish counterpart hold talks, 2nd add

For his part, Finnish Minister of Foreign Affairs, Pekka Haavisto, welcomed Safadi, lauding the depth of ties between the two countries.

 

He pointed out to the alignment of views on many issues, including climate change and human rights.

 

Haavisto said that the Kingdom’s role is central to efforts to establish peace and stability in the region.

 

Haavisto touched on the Corona pandemic and its impact on the economies of many countries in the Middle East, including Jordan.

 

“Today’s meeting was an opportunity to talk about the economic and social effects of the Corona pandemic on Jordan,” Haavisto added, stressing his country’s readiness to help Jordan in addressing the repercussions of the pandemic.

 

He also lauded the levels of cooperation between Jordan and Finland, especially in the areas of innovation and technology.

 

Haavisto commended Jordan’s leading and key role in hosting refugees, stressing that his country will continue to provide support to UNRWA and organizations specialized in supporting refugees and their human rights.

 

He also expressed his concern about some developments in the region, especially in Lebanon, and their impact on neighboring countries and the stability of the region.

 

In response to a question, Safadi pointed out to the Kingdom’s efforts in coordination and cooperation with its partners in the United States, Europe and the region to achieve calm during the recent escalation in the occupied Palestinian territories and to stop the Israeli violations in Jerusalem and the holy Al-Aqsa Mosque / Al-Haram Al-Sharif, the aggression on Gaza and preventing the displacement of the people of Sheikh Jarrah neighborhood from their homes, which would have constituted a war crime in accordance with international law.

 

Source: Jordan News Gazette

Categories
Government Policy

FM, Finnish counterpart hold talks

Deputy Prime Minister and Minister of Foreign Affairs and Expatriates, Ayman Safadi, held talks in the Finnish capital of Helsinki, with Finnish Minister of Foreign Affairs, Pekka Haavisto.

 

The talks dealt with enhancing cooperation in many fields, including technology, environment, agriculture and tourism, and addressing the impacts of the Corona pandemic, in order to bolster ties between the two countries.

 

The two ministers also discussed ways to enhance cooperation and coordination within the framework of the Jordanian-European partnership, which is witnessing constant development in various fields.

 

On the regional aspect of the talks, Safadi and Haavisto focused on efforts to find real political prospects to achieve a just and lasting peace and to ensure the provision of the necessary support to the United Nations Relief and Works Agency (UNRWA), which suffers from a severe financial deficit, the Kingdom is making intensive efforts with international and regional partners to bridge it.

 

Talks between Haavisto and Safadi, who arrived in Helsinki on the second stop of a tour that started in Norway yesterday and will end in Sweden tomorrow, also dealt with developments in the region, including efforts to reach a political solution to the Syrian crisis, support for refugees and host countries, supporting Iraq and fighting terrorism.

 

In a press conference with the Finnish Foreign Minister, Safadi said that talks discussed strengthening bilateral cooperation and the solid ties between the two countries, especially in the fields of tourism, investment, technology, agricultural technology and other fields.

 

Safadi indicated that he and his Finnish counterpart discussed regional issues and efforts to resolve the region’s crises, adding, “We continue to seek to mobilize international efforts to restore momentum to the peace process and find a political horizon for resolving the conflict on the basis of the two-state solution.”

 

Source: Jordan News Gazette

Categories
General

King expresses appreciation for Saudi support for Jordan

His Majesty King Abdullah on Tuesday received Saudi Foreign Minister Prince Faisal bin Farhan bin Abdullah, who conveyed the greetings of Custodian of the Two Holy Mosques King Salman bin Abdulaziz Al Saud and a message from him on the brotherly ties between the two countries and bolstering coordination and cooperation on regional issues.

 

During a meeting at Al Husseiniya Palace, King Abdullah expressed appreciation for Saudi Arabia’s support for Jordan in the face of various challenges, including the sedition that Jordan nipped in the bud, noting that Saudi Arabia’s messages of support are a reflection of its leadership’s policy to stand by Jordan in all circumstances.

 

His Majesty stressed that Jordan’s and Saudi Arabia’s security is one and the same, as they stand together in the face of various challenges, reaffirming the centrality of the ties between the two countries.

 

The King noted the strength of Jordanian-Saudi ties in the face of scepticism and speculation, asking the minister to convey his greetings to the Saudi monarch and wishing Saudi Arabia and its people further prosperity and progress.

 

For his part, the Saudi foreign minister expressed Saudi Arabia’s keenness to bolster cooperation with Jordan and its appreciation of the brotherly, historical ties between the two countries and leaderships.

 

Discussions at the meeting covered means of advancing bilateral ties across all sectors, and maintaining coordination and consultation between the two countries on issues of mutual concern, in service of their interests and Arab causes.

 

Director of the Office of His Majesty Jafar Hassan attended the meeting.

 

Source: Jordan News Gazette

Categories
General

Number of arrivals, departures to Jordan doubled in Q2: Interior Ministry

The number of arrivals and departures to the Kingdom, through border crossings, doubled during the second quarter of this year, reaching 1,276,000 people, an official source in the Interior Ministry Tuesday.

 

The source added that the number of arrivals and departures to the Kingdom during the first quarter of this year reached about 710,000 people.

 

Source: Jordan News Gazette

Categories
General

Media minister visits Al-Raya Media Group

Minister of State for Media Affairs, Sakher Dudin, on Tuesday visited the Al-Raya Media Group as part of a series of communication visits he is making to national media institutions.

 

Dudin urged media outlets to focus on publishing positive messages that would serve citizens and society, in parallel with zooming in imbalances without exaggeration or intimidation, and avoiding messages that cause confusion or concern in society, especially during abnormal circumstances or crises.

 

Dudin, who also the government spokesperson, called on media outlets keep abreast of modern technologies and the digital revolution, which contributes to the improvement of media messages and their delivery to all age groups, especially youth people.

 

Doudin also stressed the importance of the national role presented by local media outlets in directing public opinion and their contribution to conveying the state’s messages.

 

He underlined the importance of selecting information and news from their official sources and avoid rumors that affect the society and harm the state’s reputation.

 

During the visit, the media minister was briefed by the group’s executive director, Mohammad Musleh, on the work mechanism of the group, which includes (Hala Radio, Hala Akhbar (News), Jeish (Army) FM and Bliss Radio).

 

Source: Jordan News Gazette

Categories
Government Policy

FM, Finnish counterpart hold talks, 1st add

Safadi pointed out that the low volume of support for refugees is worrying, lauding Finland’s important role and its contribution to international efforts to provide humanitarian support to refugees and keep their cause on the international agenda.

 

He also expressed his hope to continue working with Finland to ensure continued support for refugees and host communities, including Jordan.

 

Safadi also valued the support provided by Finland to the UNRWA, noting that Finland is among the twenty countries that provided the most support to the UN agency.

 

He added that the issue of supporting the UNRWA is at the forefront of the agenda of his current tour, which includes Norway, Finland and Sweden, to ensure that the necessary funding is secured for the agency to continue providing basic services to Palestinian refugees.

 

Safadi said he was looking forward to meeting his Swedish counterpart on Wednesday to push efforts aimed at mobilizing international support for the agency.

 

He added that Jordan and Finland share many values, and said he was looking forward to continue working with Finland to build on the strong relations that unite the two countries and increase cooperation to confront the region’s crises, foremost of which is the Palestinian issue, the Syrian crisis, supporting Iraq and Lebanon, and the fight against terrorism, which poses a threat to all, stressing that Finland is a strong partner for Jordan.

 

Source: Jordan News Gazette

Categories
General

UK reports surge in daily COVID fatalities

COVID-19 killed 138 people in the UK Tuesday, the highest deaths number in a single day since March 17, taking the death toll to 129,881.

 

The Department of Health and Social Care (DHSC) said more than 21,690 people tested positive for the highly contagious respiratory disease, as the caseload nears six million.

 

Source: Jordan News Gazette

Categories
General

MoPIC, AFD strike €18.6 million wastewater treatment deal

The Planning and International Cooperation Ministry (MoPIC) and the French Development Agency (AFD) Tuesday signed an €18.6 million EU grant to treat wastewater in the Ramtha city and the Hauran region.

 

The €18.6 million tranche, which is funneled through the Neighbourhood Investment Platform (NIP), comes as part of the €98.6 million grant to support a wastewater treatment project.

 

MoPIC stated the project seeks to improve the current sewer system so that it would be able to harvest and treat wastewater, as well as link more areas in the northern city of Ramtha to the pipeline system.

 

The project aims to increase the Ramtha Wastewater Treatment Plant’s productive capacity to reach 22,000 m3 per day, compared to its current 5,400 m3 productive capacity.

 

A new 11,000 m3 productive capacity wastewater treatment plant is slated to be established; in addition, the project plans to build a power plant that would run on biogas produced as a result of the wastewater treatment.

 

Source: Jordan News Gazette

Categories
Africa MENA Pakistan Press Releases South Africa

Synchronoss Personal Cloud Solution Selected for Integration into Japan’s Kitamura Online and Retail Channels

New partnership will allow Japanese retailer to offer content storage as it seeks to digitize more of its services

BRIDGEWATER, N.J., Aug. 03, 2021 (GLOBE NEWSWIRE) — Synchronoss Technologies, Inc. (NASDAQ: SNCR), a global leader and innovator of cloud, messaging and digital solutions, today announced that Kitamura, a Japanese multimedia retailer, has selected the Synchronoss Personal Cloud solution for integration into its online and retail channel. The addition of personal cloud will give Kitamura’s online and retail customers the ability to back up and manage their valuable digital content, including photos and videos, from any device.

Kitamura is one of Japan’s leading retailers offering image-related services and products, including cameras, photo printing, video dubbing, photo studio, photo books and so on. The retailer has over 1,000 retail locations across the country with over 20 million paying visitors each year and approximately 10 million consumers registered in its online services. Through this integration, Kitamura will be able to provide seamless online and retail experience with the new white-label personal cloud offering.

“We are excited to be partnering with Synchronoss to integrate its personal cloud solutions across our online and retail channels,” said Hajime Yanagisawa, Managing Executive Officer, Kitamura. “We have always been committed to bringing customers’ memories to life through the medium of photography, and this cloud offering is the next step in not only enabling our customers to enjoy their memories but to also store, organize and manage them safely and securely. We’re looking forward to bringing this new service to our customers as we continue our journey towards digitizing our offering.”

Synchronoss’ white-label personal cloud has been adopted by mobile operators and other companies across the globe. The solution gives their customers a safe, secure cloud experience and the ability to store and sync digital content – a key to building brand loyalty and customer satisfaction in an increasingly online world. It also delivers to those organizations the flexibility to quickly add additional value-added services that strengthen the bottom line.

Anthony Socci, President of Synchronoss International, said he is delighted to be working with Kitamura on its new cloud offering. “This cloud solution will be instrumental to Kitamura as it increases its digital touchpoints and seeks to create new revenue streams beyond its traditional printing and camera retail business. We look forward to collaborating with Kitamura as it brings new, innovative services to its customers,” he said.

To learn more about Synchronoss cloud solutions, visit synchronoss.com/solutions/cloud.

About Synchronoss
Synchronoss Technologies (NASDAQ: SNCR) builds software that empowers companies around the world to connect with their subscribers in trusted and meaningful ways. The company’s collection of products helps streamline networks, simplify onboarding, and engage subscribers to unleash new revenue streams, reduce costs and increase speed to market. Hundreds of millions of subscribers trust Synchronoss products to stay in sync with the people, services and content they love. That’s why more than 1,500 talented Synchronoss employees worldwide strive each day to reimagine a world in sync. Learn more at www.synchronoss.com

About Kitamura
Kitamura is a leading company of photographic and video-related products and services in Japan. The company owns Japan’s largest in-house laboratories (photo and video processing factories) and delivers its services and products via more than 1,000 retail stores nationwide and online. It’s the company’s mission to provide services to shape customer memories not only at that moment but also for decades to come, restore photos, and revive precious memories.

Media Contacts

For Synchronoss: Anais Merlin, CCgroup, E: synchronoss@ccgrouppr.com

Investor Contact
For Synchronoss: Todd Kehrli/Joo-Hun Kim, MKR Investor Relations, Inc., E: investor@synchronoss.com

Categories
MENA Press Releases

GT Biopharma Announces Positive Preclinical Results For GTB-5550 B7H3 TriKE™

POTENTIAL TREATMENT OF SEVERAL SOLID TUMOR CANCERS INCLUDING: NON-SMALL CELL LUNG CANCER, SQUAMOUS CELL CARNINOMA, BREAST CANCER, RENAL CANCER, PANCREATIC CANCER, OVARIAN CANCER, LIVER CANCER, COLORECTAL CANCER

BEVERLY HILLS, Calif., Aug. 3, 2021 /PRNewswire/ — GT Biopharma, Inc. (NASDAQ: GTBP), a clinical stage biopharmaceutical company focused on developing target-directed, tri-specific Natural Killer (NK) cell engager therapies (TriKE™) incorporating interleukin 15 (IL-15) for the treatment of cancer, announced preclinical results for GTB-5550, its B7H3 TriKE™ product candidate as a prospective therapy for the treatment of several different types of cancers.

GT Biopharma Logo

GTB-5550 TriKE™ was evaluated in several preclinical models overexpressing B7H3, and was found to be effective at promoting NK cell killing of multiple cancer cell types.  B7H3 is over-expressed on several cancer types including non-small cell lung cancer, squamous cell carcinoma, and breast, renal, pancreatic, ovarian, liver and colorectal cancers.  GTB-5550 TriKE™ is presently undergoing GMP manufacturing scale-up in preparation for filing an Investigational New Drug (IND) application with the U.S. Food and Drug Administration (FDA) for evaluation in humans.

B7H3 is a member of the B7 family of immune checkpoint inhibitors which includes PD-1/PD-L1 and CTLA-4/CD80.  Merck’s Keytruda® (pembrolizumab) and Bristol-Myer Squibb’s YERVOY® (ipilimumab) targeting the PD-1/PD-L1 and CTLA-4/CD-80 checkpoints, respectively, have demonstrated significant survival benefit and are blockbuster immune-oncology therapeutics.

B7H3 expression on cancer cells is highly associated with undesirable treatment outcomes and survival time.  Targeting B7H3 on cancer cells with TriKE™ and redirecting NK cells to attack and kill cancer cells expressing B7H3, could result in a therapeutic treatment that limits the metastatic potential and invasiveness of certain solid tumor cancers.

Anthony J. Cataldo, GT Biopharma’s Chairman and Chief Executive Officer, commented: “We are pleased to report our GTB-5550 TriKE™ has passed this important development milestone, and demonstrated effectiveness in promoting redirected and target-specific killing by NK cells.”

About GT Biopharma, Inc.

GT Biopharma, Inc. is a clinical stage biopharmaceutical company focused on the development and commercialization of immuno-oncology therapeutic products based our proprietary TriKE™ NK cell engager platform.  The TriKE™ platform is designed to activate and redirect the target cell killing abilities of the patient’s natural killer cells (NK cells) without the need for supplemental ex vivo engineered donor or autologous NK cells, or induced pluripotent stem cells (iPSC).  The Company has an exclusive worldwide license agreement with the University of Minnesota to further develop and commercialize therapies using TriKE™ technology.  GT Biopharma’s lead TriKE™ product candidate, GTB-3550 TriKE™, is being evaluated in a multicenter Phase I/II trial (ClinicalTrials.gov NCT03214666) for the treatment of acute myeloid leukemia (AML), myelodysplastic syndrome (MDS), and other CD33+ hematopoietic malignancies.

Forward-Looking Statements

This press release contains certain forward-looking statements that involve risks, uncertainties and assumptions that are difficult to predict, including statements regarding the potential acquisition, the likelihood of closing the potential transaction, our clinical focus, and our current and proposed trials.  Words and expressions reflecting optimism, satisfaction or disappointment with current prospects, as well as words such as “believes”, “hopes”, “intends”, “estimates”, “expects”, “projects”, “plans”, “anticipates” and variations thereof, or the use of future tense, identify forward-looking statements, but their absence does not mean that a statement is not forward-looking.  Our forward-looking statements are not a guarantee of performance, and actual results could differ materially from those contained in or expressed by such statements.  In evaluating all such statements, we urge you to specifically consider the various risk factors identified in our Form 10-K for the fiscal year ended December 31, 2020 in the section titled “Risk Factors” in Part I, Item 1A and in our subsequent Form 10Q Quarterly filings with the Securities and Exchange Commission, any of which could cause actual results to differ materially from those indicated by our forward-looking statements.

Our forward-looking statements reflect our current views with respect to future events and are based on currently available financial, economic, scientific, and competitive data and information on current business plans.  You should not place undue reliance on our forward-looking statements, which are subject to risks and uncertainties relating to, among other things:  (i) the sufficiency of our cash position and our ongoing ability to raise additional capital to fund our operations, (ii) our ability to complete our contemplated clinical trials, or to meet the FDA’s requirements with respect to safety and efficacy, (iii) our ability to identify patients to enroll in our clinical trials in a timely fashion, (iv) our ability to achieve approval of a marketable product, (v) design, implementation and conduct of clinical trials, (vii) the results of our clinical trials, including the possibility of unfavorable clinical trial results, (vii) the market for, and marketability of, any product that is approved, (viii) the existence or development of treatments that are viewed by medical professionals or patients as superior to our products, (ix) regulatory initiatives, compliance with governmental regulations and the regulatory approval process, and social conditions, and (x) various other matters, many of which are beyond our control.  Should one or more of these risks or uncertainties develop, or should underlying assumptions prove to be incorrect, actual results may vary materially and adversely from those anticipated, believed, estimated, or otherwise indicated by our forward-looking statements.

We intend that all forward-looking statements made in this press release will be subject to the safe harbor protection of the federal securities laws pursuant to Section 27A of the Securities Act, to the extent applicable.  Except as required by law, we do not undertake any responsibility to update these forward-looking statements to take into account events or circumstances that occur after the date of this press release.  Additionally, we do not undertake any responsibility to update you on the occurrence of any unanticipated events which may cause actual results to differ from those expressed or implied by these forward-looking statements.

TriKE™ is a trademark of GT Biopharma, Inc.
Keytruda® is a registered trademark of Merck and Co., Inc.
YERVOY® is a registered trademark of Bristol-Myer Squibb, Inc.

For more information, please visit www.gtbiopharma.com.

Contact:

Investor & Media Relations:
David Castaneda
David@gtbiopharma.com
414-351-9758

Logo – https://mma.prnewswire.com/media/1483265/GTBP_SmallLogo_Logo.jpg